Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$14.46 - $21.8 $179,014 - $269,884
-12,380 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$15.15 - $18.89 $187,557 - $233,858
12,380 New
12,380 $219,000
Q2 2018

Aug 13, 2018

SELL
$18.56 - $22.45 $495,551 - $599,415
-26,700 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$22.15 - $31.89 $374,335 - $538,941
16,900 Added 172.45%
26,700 $597,000
Q4 2017

Feb 14, 2018

SELL
$24.23 - $30.93 $358,604 - $457,764
-14,800 Reduced 60.16%
9,800 $298,000
Q3 2017

Nov 14, 2017

BUY
$23.35 - $29.24 $574,410 - $719,304
24,600
24,600 $596,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.